Global Information
회사소개 | 문의 | 비교리스트

메타볼로믹스 : 기술과 세계 시장

Metabolomics: Technologies and Global Markets

리서치사 BCC Research
발행일 2021년 11월 상품 코드 1036283
페이지 정보 영문 157 Pages
가격
US $ 5,500 ₩ 6,613,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 1회이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,600 ₩ 7,936,000 PDF (2-5 Users) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 5회까지이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,920 ₩ 9,523,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,504 ₩ 11,428,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


메타볼로믹스 : 기술과 세계 시장 Metabolomics: Technologies and Global Markets
발행일 : 2021년 11월 페이지 정보 : 영문 157 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 메타볼로믹스 시장 규모는 2021년에 127억 달러에 달했습니다.

이 시장은 2021-2026년 12.3%의 CAGR로 확대하며, 2026년에는 227억 달러에 달할 것으로 예측되고 있습니다.

세계의 메타볼로믹스 시장에 대해 조사했으며, 시장의 개요와 제품별, 적응별, 용도별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

  • 조사의 목표와 목적
  • 이 조사를 시행하는 이유
  • 이 리포트의 신기능
  • 리포트의 범위
  • 정보원
  • 조사 방법
  • 지역적 내역
  • 애널리스트의 경력
  • BCC 커스텀 조사
  • 관련 BCC 조사 리포트

제2장 정리와 하이라이트

  • 메타볼로믹스 시장의 하이라이트

제3장 메타볼로믹스의 개요

  • 서론
  • 대사물
  • 메타볼로믹스
  • 메타볼로믹스의 역사
  • 대사 경로
  • 메타볼롬
  • 대장 미크로플로라
  • 요 메타볼롬
  • 식품 메타볼롬
  • 리피좀과 리피좀
  • Fluxomics
  • 메타볼로믹스 프로세스 스텝
  • 샘플 조제
  • 추출
  • 유도체화
  • 분리와 검출
  • 데이터 분석
  • 메타볼로믹스 테크놀러지
  • 표적 어프로치와 비표적 어프로치
  • 용도

제4장 메타볼로믹스 : 파이프라인 분석

  • 개요

제5장 메타볼로믹스 : 시장 역학

  • 메타볼로믹스 시장 촉진요인
  • 메타볼로믹스 연구에 대한 투자 확대
  • 맞춤형 의료의 수요 확대
  • 제약 및 바이오테크놀러지 연구개발비의 증가
  • 기술의 진보
  • 독물학 시험에서 메타볼로믹스의 사용 증가
  • 시장 억제요인
  • 데이터 검증과 처리에 관련된 복잡성
  • 툴과 기기의 고비용
  • 숙련된 연구자의 부족
  • 업계 인사이트
  • 시장 동향

제6장 COVID-19 팬데믹의 영향

  • 서론
  • 발생
  • 메타볼로믹스에 대한 COVID-19의 영향

제7장 세계의 메타볼로믹스 시장 내역, 제품별

  • 서론
  • 분리 기술
  • 크로마토그래피
  • 검출 기술
  • 질량분석
  • 분광법
  • 어세이
  • 바이오인포매틱스와 시스템 생물학 툴

제8장 세계의 메타볼로믹스 시장 내역, 적응별

  • 서론
  • 시장의 내역
  • 심혈관질환
  • 신경학적 질환
  • 선천성 대사이상증

제9장 세계의 메타볼로믹스 시장 내역, 용도별

  • 서론
  • 바이오마커 탐색
  • Drug Discovery
  • 독성 시험
  • 영양유전체학
  • 기능 게노믹스

제10장 세계의 메타볼로믹스 시장 내역, 지역별

  • 서론
  • 북미
  • 미국
  • 캐나다
  • 멕시코
  • 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타
  • 아시아태평양
  • 일본
  • 중국
  • 인도
  • 기타
  • 라틴아메리카
  • 중동·아프리카(MEA)

제11장 경쟁 구도

  • 세계의 기업 점유율 분석
  • 합병과 인수
  • 계약, 협업, 제품 발매 및 파트너십

제12장 기업 개요

  • AGILENT TECHNOLOGIES INC.
  • BIOCRATES LIFE SCIENCES AG
  • BIO-RAD LABORATORIES INC.
  • BIOVISION INC.
  • BRUKER CORP.
  • CHENOMX
  • DANAHER CORP.
  • DRUMETIX LABORATORIES LLC
  • GERSTEL GMBH & CO. KG
  • HUMAN METABOLOME TECHNOLOGIES AMERICA INC.
  • LECO CORP.
  • MERCK KGAA
  • METABOLOMIC DIAGNOSTICS
  • METABOLOMIC TECHNOLOGIES INC.
  • METABOLON INC.
  • ONE WAY LIVER GENOMICS S.L.
  • PERKINELMER INC.
  • PROMEGA CORP.
  • QIAGEN N.V.
  • SHIMADZU CORP.
  • STEMINA BIOMARKER DISCOVERY INC.
  • THERMO FISHER SCIENTIFIC INC.
KSA 21.11.25

List of Tables

  • Summary Table : Global Market for Metabolomics, by Product Type, Through 2026
  • Table 1 : Publications Referencing Metabolomics, 2008-2018
  • Table 2 : Major Approaches in Metabolomics and their Advantages and Disadvantages
  • Table 3 : Some Pipeline Clinical Trial Studies for Metabolomics
  • Table 4 : Recent Funding Programs in Metabolomics
  • Table 5 : Common Hyphenated Platforms in Metabolomic Research
  • Table 6 : Global Market for Metabolomics, by Product Type, Through 2026
  • Table 7 : Global Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 8 : Global Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
  • Table 9 : Global Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 10 : Mass Spectroscopy Suppliers for the Life Sciences
  • Table 11 : Global Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
  • Table 12 : High-Content Screening Suppliers and Key Attributes
  • Table 13 : Assays Commonly Used with Metabolomic Assays
  • Table 14 : Metabolomic Public Resources
  • Table 15 : Global Market for Metabolomics, by Indication, Through 2026
  • Table 16 : Representation of Pathways, Functions of Metabolites and Possible Biomarkers in Animal Model and Human-Based Studies of Various Neuropsychiatric Disorders
  • Table 17 : Global Market for Metabolomics, by Application, Through 2026
  • Table 18 : Global Market for Metabolomics, by Region, Through 2026
  • Table 19 : North American Market for Metabolomics, by Product Type, Through 2026
  • Table 20 : North American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 21 : North American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
  • Table 22 : North American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 23 : North American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
  • Table 24 : North American Market for Metabolomic Assays, by Product Type, Through 2026
  • Table 25 : North American Market for Metabolomics, by Indication, Through 2026
  • Table 26 : North American Market for Metabolomics, by Application, Through 2026
  • Table 27 : European Market for Metabolomics, by Product Type, Through 2026
  • Table 28 : European Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 29 : European Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
  • Table 30 : European Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 31 : European Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
  • Table 32 : European Market for Metabolomic Assays, by Product Type, Through 2026
  • Table 33 : European Market for Metabolomics, by Indication, Through 2026
  • Table 34 : European Market for Metabolomics, by Application, Through 2026
  • Table 35 : Asia-Pacific Market for Metabolomics, by Product Type, Through 2026
  • Table 36 : Asia-Pacific Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 37 : Asia-Pacific Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
  • Table 38 : Asia-Pacific Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 39 : Asia-Pacific Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
  • Table 40 : Asia-Pacific Market for Metabolomic Assays, by Product Type, Through 2026
  • Table 41 : Asia-Pacific Market for Metabolomics, by Indication, Through 2026
  • Table 42 : Asia-Pacific Market for Metabolomics, by Application, Through 2026
  • Table 43 : Latin American Market for Metabolomics, by Product Type, Through 2026
  • Table 44 : Latin American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 45 : Latin American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
  • Table 46 : Latin American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 47 : Latin American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
  • Table 48 : Latin American Market for Metabolomic Assays, by Product Type, Through 2026
  • Table 49 : Latin American Market for Metabolomics, by Indication, Through 2026
  • Table 50 : Latin American Market for Metabolomics, by Application, Through 2026
  • Table 51 : Middle Eastern and African Market for Metabolomics, by Product Type, Through 2026
  • Table 52 : Middle Eastern and African Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 53 : Middle Eastern and African Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
  • Table 54 : Middle Eastern and African Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
  • Table 55 : Middle Eastern and African Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
  • Table 56 : Middle Eastern and African Market for Metabolomic Assays, by Product Type, Through 2026
  • Table 57 : Middle Eastern and African Market for Metabolomics, by Indication, Through 2026
  • Table 58 : Middle Eastern and African Market for Metabolomics, by Application, Through 2026

List of Figures

  • Summary Figure : Global Market for Metabolomics, by Product Type, 2020-2026
  • Figure 1 : Publications Referencing Metabolomics, 2008-2018
  • Figure 2 : Cellular Respiration Stages
  • Figure 3 : Factors Impacting Enzyme Activity
  • Figure 4 : Typical Analytical Metabolomic Process Steps
  • Figure 5 : Schematic Representation of a Metabolomic Workflow
  • Figure 6 : Bioinformatic Processes for Metabolomics
  • Figure 7 : Global Market for Metabolomics, by Region, 2020
  • Figure 8 : Global Metabolomics Market Share Analysis, by Company, 2020
  • Figure 9 : Agilent: Annual Revenue, 2018-2020
  • Figure 10 : Agilent: Revenue Share, by Geography, 2020
  • Figure 11 : Agilent: Revenue Share, by Segment, 2020
  • Figure 12 : Bio-Rad: Annual Revenue, 2018-2020
  • Figure 13 : Bio-Rad: Revenue Share, by Segment, 2020
  • Figure 14 : Bruker: Annual Revenue, 2018-2020
  • Figure 15 : Bruker: Revenue Share, by Region, 2020
  • Figure 16 : Danaher Corp.: Annual Revenue, 2018-2020
  • Figure 17 : Danaher Corp.: Revenue Share, by Geography, 2020
  • Figure 18 : Danaher Corp.: Revenue Share, by Segment, 2020
  • Figure 19 : Merck KGaA: Annual Revenue, 2019 and 2020
  • Figure 20 : Merck KGaA: Revenue Share, by Region, 2020
  • Figure 21 : Merck KGaA: Revenue Share, by Segment, 2020
  • Figure 22 : Thermo Fisher Scientific: Annual Revenue, 2019 and 2020
  • Figure 23 : Thermo Fisher Scientific: Revenue Share, by Segment, 2020

Highlights:

The global metabolomics market should reach $22.7 billion by 2026 from $12.7 billion in 2021 at a compound annual growth rate (CAGR) of 12.3% for the forecast period of 2021 to 2026.

The separation techniques segment of the global metabolomics market is expected to grow from $5.1 billion in 2021 to $8.7 billion in 2026 at a CAGR of 11.3% for the forecast period of 2021 to 2026.

The detection techniques segment of the global metabolomics market is expected to grow from $4.0 billion in 2021 to $7.1 billion in 2026 at a CAGR of 12.4% for the forecast period of 2021 to 2026.

Report Scope:

This report examines the current and forecasted market potential for metabolomics. It offers a detailed analysis of the market background, technological advancement, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for metabolomics based on product, indication and application type.

By product, the metabolomics market is segmented into separation techniques, detection techniques, assays, and bioinformatics. By indication type, the metabolomics market is segmented into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. The others segment covers respiratory diseases, infectious diseases, etc. By application, the metabolomics market is segmented into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, and others.

By geography, the metabolomics market has been segmented into Europe, North America, Asia-Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India, and China are found in the regional segments. For market estimates, data is provided for 2020 as the base year, for 2021 and forecast through year-end 2026. Estimated values used are based on metabolomics companies' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

  • 59 tables
  • An overview and industry analysis of the global markets for metabolomics technologies
  • Analyses of global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Assessment of the key marketed products and recent product launches, regulatory landscape across different demographics covering North America, Europe, Asia-Pacific, Latin America and Middle East
  • Coverage of history and pathways of metabolomics, information on metabolomes and their sources like large bowel microflora, urine metabolome, food metabolome and comparison between lipidomes and lipidomics
  • Highlights of the market potential for metabolomics market by product, indication, application, and region; assessment of investment in metabolomic research and spending in pharmaceutical and biotech R&D
  • Information on targeted and untargeted approaches for metabolomic technology and complexity associated with data examination and processing
  • Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
  • Detailed profiles of the leading companies in the metabolomics market, including Agilent Technologies, Bio-Rad, Danaher Corp., Merck KGaA, Promega Corp. and Thermo Fisher Scientific

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • What's New in This Report
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Highlights of the Market for Metabolomics

Chapter 3 Overview of Metabolomics

  • Introduction
  • Metabolites
  • Metabolomics
  • Metabolomic History
  • Metabolic Pathways
  • Metabolomes
  • Large Bowel Microflora
  • Urine Metabolome
  • Food Metabolome
  • Lipidomes and Lipidomics
  • Fluxomics
  • Metabolomic Process Steps
  • Sample Preparation
  • Extraction
  • Derivatization
  • Separation and Detection
  • Data Analysis
  • Metabolomic Technology
  • Targeted and Untargeted Approaches
  • Applications

Chapter 4 Metabolomics: Pipeline Analysis

  • Overview

Chapter 5 Metabolomics: Market Dynamics

  • Metabolomics Market Drivers
  • Increasing Investment in Metabolomic Research
  • Increase in Demand for Personalized Medicine
  • Increasing Pharmaceutical and Biotech R&D Spending
  • Technological Advancements
  • Increasing Use of Metabolomics in Toxicology Testing
  • Market Restraints
  • Complexity Associated with Data Examination and Processing
  • High Cost of Tools and Instruments
  • Dearth of Skilled Researchers
  • Industry Insights
  • Market Trends

Chapter 6 Impact of COVID-19 Pandemic

  • Introduction
  • Outbreak
  • Impact of COVID-19 on Metabolomics

Chapter 7 Global Metabolomics Market Breakdown by Product

  • Introduction
  • Separation Techniques
  • Chromatography
  • Detection Techniques
  • Mass Spectrometry
  • Spectroscopy
  • Assays
  • Bioinformatics and Systems Biology Tools

Chapter 8 Global Metabolomics Market Breakdown by Indication

  • Introduction
  • Market Breakdown
  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism

Chapter 9 Global Metabolomics Market Breakdown by Application

  • Introduction
  • Biomarker Discovery
  • Drug Discovery
  • Toxicology Testing
  • Nutrigenomics
  • Functional Genomics

Chapter 10 Global Metabolomics Market Breakdown by Region

  • Introduction
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Chapter 11 Competitive Landscape

  • Global Company Share Analysis
  • Mergers and Acquisitions
  • Agreements, Collaborations, Product Launches, and Partnerships

Chapter 12 Company Profiles

  • AGILENT TECHNOLOGIES INC.
  • BIOCRATES LIFE SCIENCES AG
  • BIO-RAD LABORATORIES INC.
  • BIOVISION INC.
  • BRUKER CORP.
  • CHENOMX
  • DANAHER CORP.
  • DRUMETIX LABORATORIES LLC
  • GERSTEL GMBH & CO. KG
  • HUMAN METABOLOME TECHNOLOGIES AMERICA INC.
  • LECO CORP.
  • MERCK KGAA
  • METABOLOMIC DIAGNOSTICS
  • METABOLOMIC TECHNOLOGIES INC.
  • METABOLON INC.
  • ONE WAY LIVER GENOMICS S.L.
  • PERKINELMER INC.
  • PROMEGA CORP.
  • QIAGEN N.V.
  • SHIMADZU CORP.
  • STEMINA BIOMARKER DISCOVERY INC.
  • THERMO FISHER SCIENTIFIC INC.
Back to Top
전화 문의
F A Q